Terex’s stock slides as hiked outlook falls short of Street view

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Wallace Witkowski came to MarketWatch from the Associated Press in New York, where he covered the business of Big Pharma, after covering FDA regulation of many of the same companies, as well as medical devices, in the Washington, D.C., area.

Shares of Terex Corp. TEX, +0.43% declined in the extended session Tuesday after the crane and construction equipment company’s hiked outlook fell short of Wall Street expectations while announcing the retirement of its chairman and chief executive. Terex shares fell more than 3% after hours, following a 0.4% rise to close the regular session at $54.23. Terex said that John Garrison Jr.

will retire as chairman and CEO effective Jan. 1, and that Simon Meester, the company’s current president of aerial work platforms, will the next CEO. David Sachs, the current lead independent member of the Terex’s board, will become chairman. Terex also expects its full-year 2023 earnings per share results to be approximately $7.05, up from its estimate of about $7 a share back in August. Analysts surveyed by FactSet expect full-year earnings of $7.16 a share.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

NetScout’s stock drops 20% after full-year outlook reducedWallace Witkowski came to MarketWatch from the Associated Press in New York, where he covered the business of Big Pharma, after covering FDA regulation of many of the same companies, as well as medical devices, in the Washington, D.C., area.
Source: MarketWatch - 🏆 3. / 97 Read more »

Snap’s stock rallies to best day in nearly a year following user count leakWallace Witkowski came to MarketWatch from the Associated Press in New York, where he covered the business of Big Pharma, after covering FDA regulation of many of the same companies, as well as medical devices, in the Washington, D.C., area.
Source: MarketWatch - 🏆 3. / 97 Read more »